CA ARCHIVE
- Egypt Targets 60% Renewable Electricity by 2040
• Egypt aims to generate 60% of its electricity from renewable sources by 2040.
- Roundup of climate and environment news to June 28, 2026
• BC government announces new climate change strategy with reduced emissions targets by 2030.
- Roundup of climate and environment news to June 28, 2026
• British Columbia announces new climate action plan to reduce greenhouse gas emissions by 2028.
- EMA to pull Amgen’s Tavneos over ‘incorrect and misleading’ data
• EMA recommends withdrawing Amgen's Tavneos from European market due to incorrect and misleading data.
- BIO 2026: Alternatives to funding orphan drugs
• Nonprofit and for-profit companies discuss funding orphan drug development, focusing on ultra-rare diseases.
- SCE Extends Offers to Over 5,000 Community Members Impacted by Eaton Fire
* Southern California Edison offers over $700 million to 5,000 community members impacted by the Eaton Fire.
- Appointments and advancements for June 25, 2026
Cardiomech appoints new CEO, leading the biopharma company's growth in cardiovascular treatments.
- Financings for June 25, 2026
• Anodyne raises undisclosed amount in private financing.
- In the clinic for June 25, 2026
• Genfit announces positive data readout for its treatment of primary biliary cholangitis.
- Other news to note for June 25, 2026
• Abbott announces partnership with ADC for diabetes treatment development.
- 'F9' took a car into space, but 5 years on, just how ridiculous was the scene? We asked the experts - Space
• The movie 'F9' featured a car launched into space, sparking debate among experts about its realism.
- Nomic joins the HESI Global OASIS Consortium to Advance Human-Relevant Safety Assessment Through Proteomics
* Nomic Bio Inc. partners with HESI Global OASIS Consortium for liver toxicity biomarker signature identification.
- Corxel-Vincentage’s oral GLP-1 meets phase II obesity endpoints
Corxel Pharmaceuticals' oral GLP-1 receptor agonist CX-11 met primary endpoints in phase II obesity trial.
- Lilly taps Abbisko for $1.9B discovery deal
Abbisko Therapeutics partners with Eli Lilly for $1.9B discovery deal to develop innovative medicines.
- NorthX invests $3 million in Moment Energy to unlock BC's battery storage market
* NorthX Climate Tech invests $3 million in Moment Energy, a BC-based battery energy storage company.